Research ArticleClinical Investigation
Absolute Quantitation of Cardiac 99mTc-Pyrophosphate Using Cadmium-Zinc-Telluride–Based SPECT/CT
Sharmila Dorbala, Mi-Ae Park, Sarah Cuddy, Vasvi Singh, Kyle Sullivan, Sirwoo Kim, Rodney H. Falk, Viviany R. Taqueti, Hicham Skali, Ron Blankstein, Camden Bay, Marie F. Kijewski and Marcelo F. Di Carli
Journal of Nuclear Medicine May 2021, 62 (5) 716-722; DOI: https://doi.org/10.2967/jnumed.120.247312
Sharmila Dorbala
1Division of Nuclear Medicine, Department of Radiology, Brigham and Women’s Hospital, Boston, Massachusetts
2CV Imaging Program, Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts; and
3CA Program, Division of Cardiology, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
Mi-Ae Park
1Division of Nuclear Medicine, Department of Radiology, Brigham and Women’s Hospital, Boston, Massachusetts
Sarah Cuddy
2CV Imaging Program, Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts; and
3CA Program, Division of Cardiology, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
Vasvi Singh
2CV Imaging Program, Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts; and
Kyle Sullivan
1Division of Nuclear Medicine, Department of Radiology, Brigham and Women’s Hospital, Boston, Massachusetts
Sirwoo Kim
1Division of Nuclear Medicine, Department of Radiology, Brigham and Women’s Hospital, Boston, Massachusetts
Rodney H. Falk
3CA Program, Division of Cardiology, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
Viviany R. Taqueti
1Division of Nuclear Medicine, Department of Radiology, Brigham and Women’s Hospital, Boston, Massachusetts
2CV Imaging Program, Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts; and
Hicham Skali
2CV Imaging Program, Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts; and
Ron Blankstein
2CV Imaging Program, Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts; and
Camden Bay
1Division of Nuclear Medicine, Department of Radiology, Brigham and Women’s Hospital, Boston, Massachusetts
Marie F. Kijewski
1Division of Nuclear Medicine, Department of Radiology, Brigham and Women’s Hospital, Boston, Massachusetts
Marcelo F. Di Carli
1Division of Nuclear Medicine, Department of Radiology, Brigham and Women’s Hospital, Boston, Massachusetts
2CV Imaging Program, Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts; and

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 5
May 10, 2021
Absolute Quantitation of Cardiac 99mTc-Pyrophosphate Using Cadmium-Zinc-Telluride–Based SPECT/CT
Sharmila Dorbala, Mi-Ae Park, Sarah Cuddy, Vasvi Singh, Kyle Sullivan, Sirwoo Kim, Rodney H. Falk, Viviany R. Taqueti, Hicham Skali, Ron Blankstein, Camden Bay, Marie F. Kijewski, Marcelo F. Di Carli
Journal of Nuclear Medicine May 2021, 62 (5) 716-722; DOI: 10.2967/jnumed.120.247312
Absolute Quantitation of Cardiac 99mTc-Pyrophosphate Using Cadmium-Zinc-Telluride–Based SPECT/CT
Sharmila Dorbala, Mi-Ae Park, Sarah Cuddy, Vasvi Singh, Kyle Sullivan, Sirwoo Kim, Rodney H. Falk, Viviany R. Taqueti, Hicham Skali, Ron Blankstein, Camden Bay, Marie F. Kijewski, Marcelo F. Di Carli
Journal of Nuclear Medicine May 2021, 62 (5) 716-722; DOI: 10.2967/jnumed.120.247312
Jump to section
Related Articles
Cited By...
- From Stabilization to Depletion: Molecular Imaging to Measure Therapeutic Response in ATTR-CA
- Nuclear Cardiology Surrogate Biomarkers in Clinical Trials
- Deep Learning-Enabled Quantification of 99mTc-Pyrophosphate SPECT/CT for Cardiac Amyloidosis
- Molecular Imaging of Systemic and Cardiac Amyloidosis: Recent Advances and Focus on the Future
- Dual-Time-Point Posttherapy 177Lu-PSMA-617 SPECT/CT Describes the Uptake Kinetics of mCRPC Lesions and Prognosticates Patients Outcome